Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

DIVI'S LABORATORIES LTD.

NSE : DIVISLABBSE : 532488ISIN CODE : INE361B01024Industry : Pharmaceuticals & DrugsHouse : Divis Labs
BSE5946.9514.45 (+0.24 %)
PREV CLOSE () 5932.50
OPEN PRICE () 5930.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 16587
TODAY'S LOW / HIGH ()5930.00 6057.40
52 WK LOW / HIGH ()3350.05 6448.75
NSE5951.7023.75 (+0.4 %)
PREV CLOSE() 5927.95
OPEN PRICE () 5950.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 5951.70 (6)
VOLUME 359123
TODAY'S LOW / HIGH() 5928.25 6055.00
52 WK LOW / HIGH ()3350 6285.45
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1990

Management Info :

Ramesh BV Nimmagadda - Chairman Murali K Divi - Managing Director

Registered Office :

Address : 1-72/23( P)/ Divis/303,Divi Towers, Cyber Hills,Gachibowli,
Hyderabad,
Telangana-500032

Phone : 040 66966300 / 400

Website : www.divislabs.com

Registrar's Details : K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE
NEWS
05Dec Divi's Laboratories informs about disc
Divi's Laboratories has informed that it submitted the details as requir..
04Dec Divi’s Laboratories informs about disc
Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obliga..
11Nov Divi's Laboratories’ Q2FY25 consolidat
Divi's Laboratories has reported results for second quarter ended Septem..
05Aug Divi's Laboratories declines despite r
Divi's Laboratories is currently trading at Rs. 4831.00, down by 159.35..
03Aug Divi's Laboratories reports 21% rise i
Divi's Laboratories has reported results for first quarter ended June 30..
Financials
in Millions
QTR Sep 24 ANNUAL 24
Net Profit518015760
Gross Profit 7350 21320
Operating Profit 834025110
Net Sales 2302076650
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Procter&Gamble Healt (BSE)
 5679.65 (1.62%)
M.Cap ( in Cr)
9427.87
Ajanta Pharma (BSE)
 2840.60 (1.68%)
M.Cap ( in Cr)
35482.53
Astrazeneca Pharma I (BSE)
 6636.00 (0.62%)
M.Cap ( in Cr)
16590.00
Jenburkt Pharma (BSE)
 1325.60 (3.02%)
M.Cap ( in Cr)
585.03
Mankind Pharma (BSE)
 2650.55 (1.05%)
M.Cap ( in Cr)
106197.50
Shareholding Pattern
PROMOTERS 51.89%
MUTUAL FUNDS/UTI 11.92%
NON-INSTITUTION 9.8%
FI/BANKS/INSURANCE 8.56%
GOVERNMENT 0%
FII 0%
Mf Holding
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX81289.96-236.18 (-0.29%)
NIFTY24548.70-93.10 (-0.38%)
Dow Jones 44148.56-99.27 (-0.22%)
Nasdaq 20034.89347.65 (1.77%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI